About Xenios AG - a Fresenius Medical Care company

XENiOS AG developer of extracorporeal therapy systems., because the heart and the lungs are linked anatomically the right heart (ventricle) perfuses the lungs, while the left heart (ventricle) perfuses the body. No other company except XENIOS AG is offering minimally invasive disposable lung and heart therapies on one single platform.

Company Highlights
Year Founded

2013

icon-altEmployees

122

Location (HQ)

DEU

Since Last Funding

8 years 11 months

Monthly Website Visitors

1.4K

Last Funding Round

Seed

icon-altMoM Headcount Growth

-0.81%

icon-altYoY Headcount Growth

-3.93%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Medical Equipment Manufacturing

Therapeutics